When investors seek to inject growth momentum into their portfolios, tech stocks are often the first choice. Companies like ...

Australian biotech giant CSL has delayed its vaccine division spin-off due to a drastic decline in US flu immunization rates, leading to a 16.6% drop in share price. The company's revenue and profit ...

Picard Medical's stock took a nosedive following a recent decision by the Tucson medical device company's shareholders.

Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

MapLight has become the second Massachusetts-linked biotech to go public this year. The company sold 14.75 million shares at ...

Dimitri Semenikhin, the retail trader behind the Beyond Meat stock rally is piling into a small biotech that recently pivoted ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Novartis announces agreement to buy Avidity Biosciences for $12 billion. Here's why NVS is paying such a hefty premium for ...

MapLight Therapeutics is heading to the Nasdaq this morning via a $250 million IPO the biotech will use to advance its ...

AMD ( AMD) and Kratos ( KTOS) both saw repeated sales, shifting focus from hardware and defense tech toward software-driven ...

Lenskart Solutions, one of India's largest eye-wear retailers, is planning to raise up to 72.78 billion rupees, equivalent to $828.8 million, in a share offering, the latest in a wave of ...